Pharmacotherapy of Childhood Obesity

Freemark, Michael
February 2007
Diabetes Care;Feb2007, Vol. 30 Issue 2, p395
Academic Journal
The article presents an analysis of the benefits of lifestyle intervention and pharmacotherapy to the treatment of obesity in adults and children. It cites the role of biological factors in the difficulty of losing weight. Several placebo-controlled studies performed in obese adults showed that short-term benefits of sibutramine and rimonabant exceed those of orlistat and metformin. It shows that pharmacologic agents provide short-term reduction in body weight and cardiovascular risk factors.


Related Articles

  • Intragastric Balloon in Association with Lifestyle and/or Pharmacotherapy in the Long-Term Management of Obesity. Farina, Maria; Baratta, Roberto; Nigro, Angela; Vinciguerra, Federica; Puglisi, Concetta; Schembri, Roberto; Virgilio, Clara; Vigneri, Riccardo; Frittitta, Lucia // Obesity Surgery;Apr2012, Vol. 22 Issue 4, p565 

    Background: Intragastric balloon (BioEnterics Intragastric Balloon, BIB®) or pharmacotherapy are possible options for the treatment of obese patients when traditional approaches have failed. The aim of our study was to compare in obese patients the effect on weight loss and metabolic changes...

  • Pharmacotherapy for obesity in menopausal women. Samat, Ashish; Rahim, Asad; Barnett, Anthony // Menopause International;Jun2008, Vol. 14 Issue 2, p57 

    Weight gain, during and after the menopause is common. Contributing factors include ethnicity, reduced physical activity, reduced lean mass, reduced resting metabolic rate and treatment with certain drugs, e.g. steroids, insulin, glitazones. Excess body weight increases the risk of medical...

  • Review: Orlistat and sibutramine are modestly effective for weight loss at 1 year. Padwal, R. // ACP Journal Club;Jan/Feb2005, Vol. 142 Issue 1, p19 

    The article reports that orlistat and sibutramine are modestly effective for weight loss at one year. Studies of off-label therapy, drugs with high addiction potential that preclude long-term use or investigational, herbal or alternative compounds were excluded. Study quality assessment included...

  • Currently Available Drugs for the Treatment of Obesity: Sibutramine and Orlistat. Chaput, J.-P.; St-Pierre, S.; Tremblay, A. // Mini Reviews in Medicinal Chemistry;Jan2007, Vol. 7 Issue 1, p3 

    The currently available drugs for long-term treatment of obesity are sibutramine and orlistat. They have been shown to be able to induce significant weight loss, with important co-morbidity reduction, allowing the maintenance of reduced body weight for at least 1-2 years. Cardiostimulating and...

  • Track 5b: Management - pharmacotherapy.  // International Journal of Obesity & Related Metabolic Disorders;May2004 Supplement, Vol. 28, pS152 

    Presents several abstracts on pharmacotherapy. "Orlistat for the Treatment of Obesity: Cost Utility Model," by David Foxcroft; "Interactive Weight Loss Program--A Possible Tool for Obesity Management in Primary Care," by Judit Gonczi; "Changes of Lifestyle With Sibutramine for Grade II-III Obese...

  • Pharmacotherapy for the treatment of obesity has only modest benefits and should be used in combination with lifestyle modifications. Adis International Limited // Drugs & Therapy Perspectives;Jan2006, Vol. 22 Issue 1, p7 

    The article discusses the elements of treatment of obesity. This article suggests pharmacotherapy only for obese patients with a severe weight problem who have failed to lose weight by a reasonable trial of other means. Pharmacotherapies that are approved for the management of weight loss are...

  • Multidisciplinary Intervention With Sibutramine: Assessing Successful Weight Loss Predictors in Military Adolescent Dependents. Cabrera, Jorge L.; Wilks, Edward G.; Symons, Jenna E.; Blankson, Kwabena L.; Cole, Renee E. // Military Medicine;Mar2012, Vol. 177 Issue 3, p308 

    Objectives: Assess body mass index (BMI) reduction through a multidisciplinary intervention with sibutramine in adolescents of military parents and examine characteristics and behavioral traits as predictors of successful weight loss. Methods: A prospective study where participants received...

  • Choosing the Right Weight Loss Medication for Your Patient Requires Careful Consideration. Still, Christopher // Bariatric Times;Dec2015, Vol. 12 Issue 12, p3 

    The author discusses how to match a patient with the right weight loss medication given his risk, medical history and preferences. He cites the 5 Food and Drug Administration (FDA) approved pharmacotherapy options for treating obesity including phentermine, orlistat and phentermine/topiramate...

  • The Straight Dope On Weight-Loss Drugs. Fentress, Debbie; Agnew, Bruce // Diabetes Forecast;Apr2002, Vol. 55 Issue 4, p51 

    Provides information on weight-loss drugs, Xenical, Meridia and phentermine. Overview of studies on the drugs; Side effects of weight loss drugs; Contents of the drugs. INSET: Beware herbal remedies.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics